IQVIA HoldingsIQV +7.40%88 Current Ratio is 0.75 as of Mar. 2026, which is 29% below its 10-year median of 1.05. GuruFocus rates IQV with a GF Score™ of 88/100 and a GF Value™ of $248.96 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, IQVIA Holdings ranks worse than 86.05% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. IQVIA Holdings's current ratio for the quarter that ended in Mar. 2026 was 0.75.
IQVIA Holdings has a current ratio of 0.75. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If IQVIA Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for IQVIA Holdings's Current Ratio or its related term are showing as below:
IQV'
s Current Ratio Range Over the Past 10 Years
Min: 0.7 Med: 1.05 Max: 1.63
Current: 0.75
During the past 13 years, IQVIA Holdings's highest Current Ratio was 1.63. The lowest was 0.70. And the median was 1.05.
IQV's Current Ratio is ranked worse than 86.05% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96
vs IQV: 0.75
IQVIA Holdings (NYSE:IQV) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
IQVIA Holdings Current Ratio Related Terms
IQVIA Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for IQVIA Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IQVIA Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IQVIA Holdings Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where IQVIA Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IQVIA Holdings (IQV) has a Current Ratio of 0.75 as of Mar. 2026. This is 29% below median its historical median of 1.05. Over the past decade, IQVIA Holdings' Current Ratio has ranged from 0.70 to 1.63. According to the industry distribution chart, IQVIA Holdings ranks #185 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 86%.
Is IQVIA Holdings' Current Ratio too high?
IQVIA Holdings' current Current Ratio of 0.75 is 29% below median its 10-year median of 1.05. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 1.63. The Medical Diagnostics & Research industry median Current Ratio is 1.96. IQVIA Holdings' value of 0.75 is 61.7% below this industry median. Based on the distribution chart, IQVIA Holdings ranks #185 out of 215 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, IQVIA Holdings has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Current Ratio compare to NTRA and ILMN?
According to the Medical Diagnostics & Research industry distribution chart, IQVIA Holdings ranks #185 out of 215 companies for Current Ratio. This places IQVIA Holdings in the lower half of its industry. The industry median Current Ratio is 1.96. IQVIA Holdings' value of 0.75 is 61.7% below this benchmark. Historically, IQVIA Holdings' own Current Ratio has ranged from 0.70 to 1.63 over the past decade. While the company's 10-year median is 1.05 vs. the industry median of 1.96, IQVIA Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.96, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IQVIA Holdings's current Current Ratio of 0.75 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IQVIA Holdings's current Current Ratio is 0.75, which is 29% below median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (IQV) is currently considered Modestly Undervalued. The stock's GF Value™ is $248.96, compared to a current price of $183.95 — trading 26.1% below its estimated fair value. The current Current Ratio is 0.75, which is 29% below median its 10-year median of 1.05 and 61.7% below the Medical Diagnostics & Research industry median of 1.96. IQVIA Holdings' overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For IQVIA Holdings (IQV), the current Current Ratio is 0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IQVIA Holdings (IQV) Overvalued in 2026?
Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued.
The current stock price of $183.95 is trading 26.1% below its estimated GF Value™ of $248.96.
GuruFocus considers IQVIA Holdings to be Modestly Undervalued.
Key valuation signals for IQV:
Current Ratio: 0.75 (29% below median its 10-year median of 1.05)
GF Value™: $248.96 vs. price of $183.95 (26.1% below fair value)
Industry Position: 61.7% below the Medical Diagnostics & Research median (#185 of 215)
No single metric tells the full story. See the IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
88GF Score
Get the complete analysis for IQV
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IQV has been successfully added to your 
